Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You know things are perking up when daily transactions > daily posts on BB !
:)
So much Karma here on this BB whilst waiting for the golden RNS - compare it to the bloodshed at Orph whilst PIs waiting for the golden RNS.
Ed said we were looking at Q3 for leap IPO.as we all know that is 11 weeks at the max,
Just a little more patience required then hopefully we will all be handsomely rewarded!
Way undervalued. And will be even more undervalued soon. Happy holder!
Further investment in SWB.
More info on the FPP RNS https://www.lse.co.uk/rns/FPP/update-on-intended-acquisition-1o9f68nr50bakxf.html
The CLNs
The CLNs will convert into ordinary shares in the capital of CiiTECH which will be acquired by the Company upon completion of the acquisition of CiiTECH's existing issued share capital.
The consideration for the Intended Acquisition will be satisfied by the issue of ordinary shares in the capital of FPP ("Consideration Shares") to the CiiTECH Shareholders (including the CLN holders).
Almost market close and the RNS still hasn't been posted on LSE. For anyone who hasn't seen it:
"Investment in a cannabis healthcare company, CiiTECH Limited
FastForward Innovations Ltd, (AIM:FFWD) the listed investor focused on fast-growing and industry leading businesses, is pleased to announce that it has participated in the £2.1 million issuance of Convertible Loan Notes, (the "CLN") by research-led cannabis healthcare company, CiiTECH Limited, ("CiiTECH").
The Company took £175,000 of the issue, funding its investment in the 24-month CLN through its existing cash resources.
The CLNs are being issued ahead of CiiTECH's intended reverse takeover by Fragrant Prosperity Holdings Limited, (LSE: FPP) announced on 24 May 2021. CiiTECH will use the capital raised via the CLN to fund its marketing strategy, invest in new talent, build essential operational infrastructure to support future growth and finance the intended reverse takeover."
Presumably, when the reverse takeover happens, FFwd/Seed will receive shares in FPP at a 20% discount to market.
Be nice to clear that resistance at 8.75-9p.
well there now paying a fraction higher than Friday now after all this news, lets see if there's any takers, thought we would be above the last placement rise by now .
It doesn’t help that LSE have failed to post the RNS
KNB CBX were obvious flips. Making decent short term trades.
All the major investments have a few things in common - vertical integration, ability to scale, global ambitions etc
A lot of the recent cannabis listings are destined for ultimate failure (and will remain lifestyle rather than life-changing long term investments) due to not having any of the above.
LGP Yooma Eurox Nothern Leaf SW Brands all have common themes running through them.
Typically CLN's are an absolute scourge for a company with limited funding alternatives. It's in the CLN providers interest to have the share price as low as possible, so on conversion their notes buy more shares.
Ffwd have <9% of the total CLN, who owns the main part of the deal and what are their intentions? Perhaps Ed knows and is piggybacking on the trade.
Or it could be one of the very very rare cases where the CLN is a genuine deal to provide relatively cheap finance (10% pa) to a small company so it can grow!
not a good idea Fatman, the two flips we did KNB and CBX were good in and outs, but our latest investments are not, plus if we did start flipping every cannabis stock we bought I'm sure the ones who are looking for long term partners would bypass FFWD.
I dont know how other investors feel about it but i would be quite happy to see us flip these for a nice tidy profit as we did KNB.it would be inline with our short,medium and long term investments.i like the idea of building a steady income stream while waiting for our bigger investments to deliver.
I would be interested to hear other investors thoughts?
httpS://stockhead.com.au/health/cannabis-stocks-celebrate-pershing-ownership-change/
Mentions Little Green Pharma (ASX:LGP) as a possible beneficiary.
Just to avoid confusion with the Curaleaf heading the investment announced today by RNS is in CiiTECH. It is a Cannabis Wellness company. Another good opportunity sourced by FFWD.
And another step forward in delivering on the strategy. Great progress being made now.
Doggo
‘ It’s one of the last posts I’ll be doing once the name change happens I’m stepping back.’
I can understand, you’ve been giving ffwd cpr for years now and it’s still flatlining at 8!
There really are some precious Marys on this board. This is just a torally irrelevant bb. In a few years we all be dead. Who cares.
It’s one of the last posts I’ll be doing once the name change happens I’m stepping back.
Excellent informative post there doggo, thanks for that.
So why have FFWD invested?
Because in May they became the first company to provide domestically-produced THC oils into the German market. Up to now the market has been dependant on Canadian produced products.
Quote Eurox MD
“We will be the first medical cannabis company in Germany to be able to say our oils are ‘Made in Germany’ and we believe they will be a real winner in the German domestic market,”
Also they have been awarded German license to produce Dronabinol. German market for Dronabinol was worth around €40 million last year.
Their 10,000 sq ft facility has been awarded
Full GMP status so they can now press ahead to full capacity of 50 tonnes. A huge amount..
The company is now primed for lift off
Quote Eurox MD
“All our licences are in place; import, export, distribution, sales and now we have the licence to manufacture Dronabinol – what we now need is the product.”
“It is currently progressing through its three-month period in the stability chambers and, once cleared, we will be able to sell into the market come early May.”
Currently in talks with brand partners (hello SW Brands)
Quote
“Together with a brand partner in Germany, our aim is to lock-out competition. If you’re a believer in the ‘Made in Germany’ story then , effectively that will be us – we will be the sole supplier. “
They have big plans...
Quote
“And, once we have the German market locked down then we may well look to other European countries such as France and the UK.”
The Eurox MD is very confident they will have huge advantage over Aphria & Aurora because
Quote
the ultimate, seed-to-sale, ‘Made in Germany’ supply chain benchmark may be hard to achieve because of the stringent rules around crop production which make it hard to produce at reasonable cost and without pesticides.”
Also now in place are supply agreements with partners in Canada and an organic producer in Spain.
currently working with the University of Frankfurt on the efficacy of cannabis medicines for a range of conditions eg opioid addiction.
Also have a partnership with leading British pharmaceutical company IPS to operate the Integro Medical Clinics in the UK. Opened in Harley Street. Can provide a range of over 50 different cannabis treatments to private patients.
Also currently developing a CBD wellness brand for the European nutraceutical market and looking to secure authorisation through the Novel Food pathway.
Here is the kicker and one I haven’t thought about but is very significant to our European investments
“As the market matures and develops the European Union may well become protective of the revenues it can generate and the jobs it can create,”
This is a very serious company and thanks to Alfredo we are now invested.
By your calc 20 x 1.8m (net assets) is 36mill.
9% of that is 3.24 mill. Ffwd paid 3mill for just under 9% so that sounds about the correct valuation. Six months on from December 31st and likely net asset has also increased.
The more money that they have raised the higher the asset Mn. so the historical one is just that, you are right of course but they know what they are doing hopefully and are not looking to waste money . Doesn't take much looking into to see the reasoning behind the fundraise and the possibilities.
Some news for sure but the investment values a company at c. 20 net assets from Dec 2020 so looks like a very rich price to have paid. Would be interested to understand how they justified this price.